RxDoctor Payments Data

Marc Serve, DO

Family Medicine · Columbus, OHNPI 1013300425

Payments from drug & device makers

$450in general payments, 2019–2025

Across 13 payments — averaging $34.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironshore Pharmaceuticals Inc.$137
  • Novo Nordisk$124
  • Exact Sciences$64
  • Lilly USA, LLC$42
  • Pfizer$21
  • Merck$16
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$450 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$20,096
Medicare patients
63
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$20,494
EliquisApixaban18$19,578
ShingrixVaricella-Zoster Ge/As01b/Pf18$3,905
SynthroidLevothyroxine Sodium12$1,364
Atorvastatin Calcium97$589
Gabapentin21$559
Losartan Potassium55$520
Levothyroxine Sodium31$427
Albuterol Sulfate HfaAlbuterol Sulfate19$336
Pantoprazole Sodium28$327
Omeprazole26$274
Rosuvastatin Calcium28$273
Metoprolol Succinate19$248
Amlodipine Besylate34$213
Temazepam12$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$124$20,49411 claims
PfizerEliquis$21$19,57818 claims
AbbVieSynthroid$16$1,36412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →